Characteristics, Treatment Patterns, and Outcomes of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of Health Insurance Claims Data in Germany [0.03%]
德国健康保险理赔数据的回顾性分析：2007-2016年间接受根治性膀胱切除术的肌层浸润性膀胱癌患者的特点、治疗模式和结局特征
Jennifer Stuart,Evi Zhuleku,Antje Mevius et al.
Jennifer Stuart et al.
Introduction: Muscle-invasive bladder cancer (MIBC) is an aggressive form of bladder cancer characterized by high rates of metastasis and recurrence. Given recent advances in the treatment landscape, real-world evidence o...
Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting [0.03%]
转移性去势抵抗性前列腺癌的治疗策略：后 ARTA、化疗药物多西他赛后的考虑因素叙事综述
Kenrick Ng,Birth-Lynn Tyers,Aruni Ghose et al.
Kenrick Ng et al.
The management of advanced prostate cancer has evolved significantly with the advent of androgen receptor-targeted agents (ARTAs) and docetaxel, which now form the cornerstone of first-line systemic therapy in advanced disease. However, as ...
Expanding Head and Neck Surgical Services in East Africa through Innovative Training Initiatives [0.03%]
通过创新培训计划在东非扩大头颈外科服务范围
K Thomas Robbins,Johannes Fagan,Douglas Senyonjo et al.
K Thomas Robbins et al.
Similar to other sub-Saharan regions, east African countries struggle to meet their overwhelming medical challenges, including a lack of well-trained doctors. New strategies for sub-speciality training are underway that may improve the work...
Toward Personalized Treatment of Urogenital Cancers: The Role of Patient-Derived Organoids [0.03%]
朝向尿路生殖系统癌症的个性化治疗：患者来源类器官的作用
Serena Sagliocchi,Michele Musone,Stefano Chianese et al.
Serena Sagliocchi et al.
Urogenital cancers, including prostate, kidney, and bladder cancer, remain a significant clinical challenge due to their high incidence, molecular heterogeneity, and frequent resistance to standard therapies. Despite progress in genomic pro...
Activation of SV2B Inhibits Matrix-Stiffness-Induced Tumorigenesis and EMT in Glioma via FAK/PI3K/AKT Signaling Pathway [0.03%]
SV2B活化通过FAK/PI3K/AKT信号通路抑制基质硬度诱导的胶质瘤肿瘤发生及上皮间充质转化
Dengzhen Ma,Yunda Wang,Longyu Sang et al.
Dengzhen Ma et al.
Introduction: Growing evidence suggests that increased matrix stiffness can significantly enhance the malignant characteristics of glioma cells. However, the mechanisms by which increased matrix stiffness regulates the tu...
Social Determinants of Health in Metastatic Breast Cancer Care: A Podcast Exploring Challenges and Opportunities in the United States and Canada [0.03%]
影响转移性乳腺癌护理的社会决定因素：探讨美国和加拿大面临的挑战与机遇的播客
Monique Gary,Karen Gelmon,Joanne C Ryan
Monique Gary
The influence of social determinants of health (SDOH) on clinical outcomes for patients with cancer has become increasingly clear in recent years. This podcast, featuring a breast surgeon from the USA and a breast medical oncologist from Ca...
Burgeoning Non-Muscle Invasive Bladder Cancer Space: AUA 2025 Clinical Trials Presented (Doctor/Patient Podcast) [0.03%]
日益增长的非肌层浸润性膀胱癌领域：AUA 2025临床试验展示（医生/患者播客）
Rick Bangs,Roger Li
Rick Bangs
In this plain language podcast, the authors discuss highlights from the American Urological Association (AUA) Annual Meeting 2025. These insights come from the perspective of an expert patient and physician, both of whom have experience and...
The Role of Comorbidities in Treatment Decision-Making across the Spectrum of Prostate Cancer: A Podcast [0.03%]
共病在前列腺癌治疗决策中的作用：播客
Peter Whelan,Kirsty Balachandran,Kenrick Ng
Peter Whelan
Effective management of prostate cancer requires an approach that integrates oncological intent with careful consideration of coexisting comorbidities and functional reserve. This podcast explores how chronic health conditions, frailty and ...
Qualitative Interviews on the Experience of Orally vs. Intramuscularly Administered Endocrine Therapy for Advanced Breast Cancer: Patient and Healthcare Provider Perspectives [0.03%]
关于晚期乳腺癌患者接受口服或肌肉注射内分泌治疗体验的定性访谈：从患者和医疗保健提供者的角度观察
Rebecca M Speck,Gale Harding,Aarti R Chawla et al.
Rebecca M Speck et al.
Introduction: The selective estrogen receptor degraders (SERD) have proven to be an effective treatment option for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) ...
Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer [0.03%]
IMscin002研究：非小细胞肺癌患者阿特朱单抗皮下注射与静脉输注的倾向性分析
Margarita Majem,Busyamas Chewaskulyong,Zanete Zvirbule et al.
Margarita Majem et al.
Introduction: The primary analysis of IMscin002 (NCT05171777) demonstrated that most patients preferred atezolizumab subcutaneous (SC) administration over intravenous (IV) administration; we report patient preference acco...